Tag: R&D

The funds raised will be strategically deployed towards AgriTech company's aggressive expansion plans, deepening its R&D capabilities, and strengthening its technology infrastructure

The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.

Institutes under the Department of BioTechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation Genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies

Marking its first foray in India, Sorbonne Business School, a leading French institute with a rich legacy of more than 65 years stands out for its dynamic research in management

Dr Anil Gulati, Chairman and CEO, Pharmazz Inc. answers our questions on the company’s current operations in India and globally, its R&D initiatives, key disease areas and long-term plans.

This is the first novel technology that utilises machine learning to analyse unique ultraviolet light “fingerprints” on cell cultures to quickly identify presence of contamination

The Cover Story analyzes the blockbuster opportunity for India's biopharma industry. Read interviews of Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited; Sachin Joshi, MD & Founder, PharmNXT Biotech; Mandeep Singh Kumar, MD and Vice President, Medtronic India; and Harshvardhan Bhagchandka, President, IPL Biologicals

This investment will enable Perkant Tech to enhance its AI-powered prognostic technology, accelerate the R&D efforts and support market expansion, and customer acquisition strategies as the company gears up for its commercial launch

The Cover Story tracks the surge in the big-ticket investments by MNCs to spearhead the next wave of innovation. Read interview of Shailendra Vyas CEO and Director, Bioheaven360 Genotec. Expert Insights by Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA; and Ninad Karandikar, Co-founder, Stance Health

To acquire R&D center at Saint-Julien-en-Genevois, France